Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02223286 · ClinicalTrials.gov registry record

Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making

A clinical trial, sponsored by CardioDx.

Completed
Registry status
552
Enrollment target

NCT02223286: Completed study, sponsored by CardioDx.

NCT02223286 is a clinical trial that has completed, run by CardioDx. The registered enrollment target is 552 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02223286 has completed, sponsored by CardioDx.

COMPLETED
Registry status
552 participants
Enrollment target

Study Summary

The purpose of this study is to understand the use of Corus CAD also known as Age/Sex/Gene Expression score (ASGES) in the clinical decision making process of patients who underwent the evaluation of chest pain or anginal equivalent symptoms. Specifically, to better understand whether the use of the assay in clinical decision making resulted in changes in noninvasive diagnostic test ordering or diagnostic yield of additional tests ordered and/or invasive angiography.

Primary Outcome

The primary study endpoint was the percentage of patients for whom advanced diagnostic testing was ordered-stress testing with imaging, computed tomography angiography, or invasive coronary angiography.

Interventions

  • DIAGNOSTIC_TEST Corus CAD

Trial Details

FieldValue
Enrollment Target 552 participants
Start Date 2013-03
Est. Completion 2014-08
CardioDx

11 total trials

What the finished NCT02223286 record still lists

NCT02223286 is an observational study that tracks outcomes without assigning an intervention. The registered 552 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Corus CAD is the first listed.

NCT02223286 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02223286 about?

NCT02223286 is a clinical study titled "Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making". The purpose of this study is to understand the use of Corus CAD also known as Age/Sex/Gene Expression score (ASGES) in the clinical decision making process of patients who underwent the evaluation of chest pain or anginal equivalent symptoms. Specifically, to better understand whether the use of the...

What is the current status of trial NCT02223286?

This trial is currently completed. The enrollment target is 552 participants. The study started on 2013-03. Estimated completion is 2014-08.

What interventions are being tested in trial NCT02223286?

The interventions under investigation include: Corus CAD (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT02223286?

This trial is sponsored by CardioDx, which has 11 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06217809 · 552 participants · NA

    EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.

  • NCT07146022 · 552 participants · Phase 3

    Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

  • NCT05786924 · 554 participants · Phase 1

    Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • NCT01852448 · 550 participants

    Genetics of Insulin and Incretins in Cystic Fibrosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02223286, the US trial registry maintained by the National Library of Medicine. NCT02223286 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.